Trials / Not Yet Recruiting
Not Yet RecruitingNCT07360158
BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
Post-market Study for the CorSky Family of ICDs
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 151 (estimated)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CorSky ICD or CRT-D | Subjects with an indication for an ICD or CRT-D device will be implanted with a CorSky device of the CorSky ICD family according to standard implantation procedures. Device programming will be done according to the medical needs of the subjects. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2027-05-01
- Completion
- 2028-05-01
- First posted
- 2026-01-22
- Last updated
- 2026-03-06
Source: ClinicalTrials.gov record NCT07360158. Inclusion in this directory is not an endorsement.